Sign In
Buy MDT
$77.95
+4.20 (+5.69%)
At Close: Jun 03, 2026
Dividend Kings Of The Future
01:33pm, Tuesday, 18'th Mar 2025
A list of 9 companies that may reach Dividend King status in the near future. These companies span various sectors and offer investors a wide range of dividend growth rates and yields. A few of these
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 18'th Mar 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Dividend Stocks That Motley Fool Experts Are Watching Right Now
12:01pm, Monday, 17'th Mar 2025
In today's uncertain economic landscape, dividend stocks can serve as anchors in your portfolio. We asked Motley Fool investment experts Matt Argersinger and Anthony Schiavone -- leaders of The Motley
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
01:10pm, Wednesday, 12'th Mar 2025
RMD, GEHC and MDT are expected to thrive as NVIDIA and other AI leaders' MedTech ventures accelerate digital adoption within the space.
The Big 3: KO, MDT, LHX
12:20pm, Tuesday, 11'th Mar 2025
Stability is Kenny Polcari's theme when it comes to today's Big 3. He explains why Cola-Cola (KO), Medtronic (MDT) and L3Harris (LHX) are undervalued names with quality.
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
09:40am, Monday, 10'th Mar 2025
At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.
CGS Transforms Workplace Training with Cicero, a New AI-Driven, Customizable Roleplay Platform
07:00am, Monday, 10'th Mar 2025
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- CGS Immersive™, the leader in enterprise learning that is modernizing training and development with AI and XR technologies, today introduced Cicero™, a
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
02:00pm, Sunday, 09'th Mar 2025
CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON
2 Dependable Dividend Stocks That Can Pay You for Life
08:15am, Friday, 07'th Mar 2025
What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how juic
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
04:30pm, Thursday, 06'th Mar 2025
GALWAY, Ireland , March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal y
February Worst Month Since September of 2023 – Grab Our 5 Favorite Dividend Aristocrats Now
12:34pm, Monday, 03'rd Mar 2025
The NASDAQ composite index has been scorching hot since the fall of 2022, as the Magnificent 7 drove the markets to all-time highs.
Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
01:21am, Tuesday, 25'th Feb 2025
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U.S. President Donald Trump's tariff plans, a company exe
Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock
01:15pm, Monday, 24'th Feb 2025
Medtronic's Medical Surgical segment faces challenges in the third quarter due to shifts in U.S. distributor buying patterns.
US FDA approves Medtronic's medical device for Parkinson's disease
09:18am, Monday, 24'th Feb 2025
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
09:00am, Monday, 24'th Feb 2025
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland , Feb. 24, 2025
